Patents by Inventor Jon Meigh

Jon Meigh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8436024
    Abstract: The invention provides compounds of formula wherein R1, R3, R4, R5, R6, R7, L, X and Y are as defined in the specification; together with processes and intermediates for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of human neutrophil elastase.
    Type: Grant
    Filed: October 1, 2010
    Date of Patent: May 7, 2013
    Assignee: Astrazeneca AB
    Inventors: Andiappan Murugan, Lena Kristina Bergstrom, Anna Kristoffersson, Martin Lindsjö, Peter Olof Sjö, Mark David Ashton, Jon Meigh
  • Publication number: 20110082155
    Abstract: The invention provides compounds of formula wherein R1, R3, R4, R5, R6, R7, L, X and Y are as defined in the specification; together with processes and intermediates for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of human neutrophil elastase.
    Type: Application
    Filed: October 1, 2010
    Publication date: April 7, 2011
    Applicant: AstraZeneca AB
    Inventors: Andiappan Murugan, Lena Kristina Bergstrom, Anna Kristoffersson, Martin Lindsjö, Peter Olof Sjö, Mark David Ashton, Jon Meigh